Trial Profile
Randomized, Single Blinded Controlled Trial for Evaluation of the Safety and Efficacy of Loteprednol Versus Fluorometholone After Photorefractive Keratectomy for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2018
Price :
$35
*
At a glance
- Drugs Fluorometholone (Primary) ; Loteprednol etabonate (Primary)
- Indications Myopia
- Focus Therapeutic Use
- 29 Nov 2016 New trial record